No recommendation
No news or research item is a personal recommendation to deal. Hargreaves Lansdown may not share ShareCast's (powered by Digital Look) views.
(Sharecast News) - AIM-listed medtech group Inspiration Healthcare (IHC) has announced it is buying American respiratory device company Airon Corporation for $2.5m.
The deal, which comprises an initial upfront cash payment of $1.5m plus an earn out of up to $1m dependent on the delivery of future revenues, gives IHC access to a "significant strategic market" in the US, the company said in a statement.
IHC is currently awaiting approval from the US Food and Drug Administration for the SLE6000 neonatal ventilator which it aims to launch in the second half of 2025.
"The acquisition of Airon provides an established platform for US market entry for the SLE6000 and other products in the company's portfolio, enabling the group to leverage Airon's established US presence, brand, and reputation for high quality specialist products," IHC said.
Chief executive Neil Campbell said the acquisition is an "important strategic milestone" for IHC.
"The potential approval of the SLE6000 represents a significant commercial opportunity and Airon gives the group an established direct presence and expertise in the USA, which will accelerate and de-risk our commercial strategy."
The value of investments can go down in value as well as up, so you could get back less than you invest. It is therefore important that you understand the risks and commitments. This website is not personal advice based on your circumstances. So you can make informed decisions for yourself we aim to provide you with the best information, best service and best prices. If you are unsure about the suitability of an investment please contact us for advice.